What are the causes of concentric left ventricular hypertrophy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Concentric Left Ventricular Hypertrophy

Concentric LVH develops primarily from chronic pressure overload, with systemic hypertension being the most common cause, followed by aortic stenosis. 1

Primary Pressure Overload Conditions

Systemic Hypertension

  • Hypertension is the most frequent cause of concentric LVH, representing an adaptive response to chronically elevated systemic pressure coupled with high peripheral resistance. 1
  • Nighttime systolic blood pressure elevation is independently associated with concentric hypertrophy development in resistant hypertension patients (OR 1.69,95% CI 1.32-2.17). 2
  • Non-dipping blood pressure patterns (absence of >10% nocturnal BP decrease) show significantly higher prevalence of concentric hypertrophy compared to dippers (71.4% vs 38.5%, p<0.043). 3
  • Longstanding untreated hypertension particularly increases risk for concentric remodeling and subsequent concentric hypertrophy. 1

Valvular Heart Disease

  • Aortic stenosis is the second most common cause, creating severe pressure overload that drives concentric hypertrophic remodeling. 1, 4
  • The pressure gradient across a stenotic aortic valve forces the left ventricle to generate higher systolic pressures, triggering parallel addition of sarcomeres and wall thickening. 5

Secondary and Contributing Factors

Age-Related Changes

  • Progressive aging accelerates left ventricular hypertrophy development independent of blood pressure. 6
  • Each decade of age increases odds of concentric hypertrophy (OR 1.51,95% CI 1.00-2.27). 2

Obstructive Sleep Apnea

  • Clinically significant OSA (apnea-hypopnea index >15 events/hour) is independently associated with concentric hypertrophy in resistant hypertension (OR 2.73,95% CI 1.26-5.93). 2
  • OSA prevalence reaches 43% in resistant hypertension patients with concentric hypertrophy. 2

Demographic and Genetic Factors

  • Black race appears to accelerate left ventricular hypertrophy development beyond that explained by blood pressure alone. 6
  • Disorders with increased sympathetic outflow may accelerate the hypertrophic process. 6

Athletic Training Patterns

  • Isometric or strength training produces concentric hypertrophy, contrasting with endurance exercise which causes eccentric patterns. 1
  • This represents physiological rather than pathological adaptation in athletes. 4

Infiltrative and Storage Diseases

Cardiac Amyloidosis

  • Amyloid protein deposition causes concentric wall thickening with restrictive physiology. 4
  • Multiparametric CMR demonstrates elevated native T1 (>1122 ms), increased ECV (>46%), and diffuse non-vascular late gadolinium enhancement patterns in amyloid-related concentric LVH. 7

Fabry Disease

  • Glycosphingolipid accumulation in cardiomyocytes produces concentric hypertrophy, particularly affecting the posterior and lateral walls. 4

Cardiac Sarcoidosis

  • Granulomatous infiltration can produce concentric hypertrophic patterns, though often with patchy distribution. 4

Hypertrophic Cardiomyopathy

  • Genetic sarcomeric protein mutations cause primary concentric hypertrophy, typically with asymmetric septal involvement but can present with concentric patterns. 4

Pathophysiological Mechanism

The fundamental mechanism involves sarcomeres added in parallel rather than series, increasing myocyte cross-sectional area and wall thickness without chamber enlargement. 5 This adaptive response to chronic pressure overload maintains normal wall stress initially but carries substantial long-term cardiovascular risk including:

  • Reduced coronary blood flow per gram of muscle and limited coronary vasodilator reserve even without epicardial coronary disease. 5
  • Increased sensitivity to ischemic injury with larger infarcts and higher mortality rates. 5
  • Severe diastolic dysfunction with impaired relaxation and elevated filling pressures. 8
  • Loss of radial and longitudinal myocardial function. 1, 8

Clinical Pitfalls

Do not assume ECG voltage criteria alone indicate true anatomic LVH—thin body habitus, chest wall configuration, and electrode positioning create false-positive ECG patterns despite normal cardiac dimensions on echocardiography. 9 Always confirm with echocardiographic measurement of left ventricular mass index (>115 g/m² in men, >95 g/m² in women) and relative wall thickness (≥0.42 for concentric pattern). 5, 8

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Determinants of concentric left ventricular hypertrophy in patients with resistant hypertension: RESIST-POL study.

Hypertension research : official journal of the Japanese Society of Hypertension, 2015

Guideline

Concentric Hypertrophy vs Eccentric Hypertrophy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Concentric Left Ventricular Remodeling

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

ECG Voltage Criteria Frequently Produce False‑Positive LVH Compared with Echocardiography

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What does concentric left ventricular hypertrophy with a left ventricular mass index of 118 g/m², relative wall thickness of 0.45, normal global wall motion and contractility, a left ventricular ejection fraction of 59% (biplane Simpson's method), intact interventricular septum, and normal atria and right ventricle indicate, explained in layman's terms?
Can severe critical illness cause Left Ventricular Hypertrophy (LVH)?
Can left ventricular hypertrophy (LVH) cause a murmur?
What are the causes and associated ECG changes of concentric and eccentric left ventricular hypertrophy (LVH)?
What is the initial workup and management for a patient with left ventricular hypertrophy (LVH) and chest pain?
In a patient receiving systemic glucocorticoids who develops acute muscle weakness with hypokalemia, is the cause steroid‑induced hypokalemia rather than a primary hypokalemic periodic paralysis?
How should iron deficiency without anemia be treated?
What alternative treatment options are available for a patient with a first episode of vulvovaginal candidiasis caused by Candida albicans that failed to respond to three doses of oral fluconazole 150 mg given every three days?
What tetanus prophylaxis (tetanus toxoid vaccine and tetanus immune globulin) should be given for a dirty (contaminated) wound based on the patient’s immunization history?
What is the appropriate diagnostic work‑up and management for a patient with concentric left ventricular hypertrophy (LVH) and moderate pulmonary hypertension (PH)?
Can boric acid be used to treat Candida albicans vulvovaginitis in a patient who has failed three oral fluconazole 150 mg doses given every three days?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.